Skip to main content

Day: July 8, 2020

IBC Announces Appointment of Mark Smith as CEO

FRANKLIN, Ind., July 08, 2020 (GLOBE NEWSWIRE) — IBC Advanced Alloys Corp. (“IBC” or the “Company”) (TSX-V: IB; OTCQB: IAALF) is pleased to announce that the IBC Board of Directors has appointed Mark Smith, IBC Board Chairman, as Chief Executive Officer (“CEO”) of the Company effective immediately. “I am honored to take on this position and I look forward to working even more closely with IBC’s highly talented team as we intensify the effort to unleash the full potential of this unique and strategically important Company and the mission critical alloys products we manufacture,” said Mr. Smith. “IBC achieved net profitability in the calendar second quarter, in spite of impacts from the COVID pandemic, and the team and I are committed to building on that success in the quarters and years ahead.”Mr. Smith will retain his role as IBC...

Continue reading

Firan Technology Group Corporation (“FTG” or “the Corporation”) Announces Second Quarter 2020 Financial Results

TORONTO, July 08, 2020 (GLOBE NEWSWIRE) — Firan Technology Group Corporation (TSX: FTG) today announced financial results for the second quarter 2020.Achieved a book-to-bill ratio in Q2 of 0.97:1 Ended Q2 2020 with over $50M in total backlog, of which $28M is due in Q3 2020Generated $3.0M in cash in Q2 and ended the quarter with $6.4M in net cash on the balance sheetAchieved highest gross margin percentage of 32.3%Achieved net income of $2.0M in the quarter (7.6% of sales)Received $0.8M in Canadian Emergency Wage Subsidy in the quarterReceived $3.3M ($2.4M USD) in loans from the US Paycheck Protection Program (PPP), which can be forgiven in future periods if certain conditions are metSubsequent to quarter-end, FTG entered into a new 2 year, $20M USD committed credit facility on terms similar to the previous agreementSecond Quarter...

Continue reading

Algonquin Power & Utilities Corp. Announces C$900 Million Offering of Common Shares Comprised of C$550 Million Bought Deal Offering and Concurrent C$350 Million Offering to an Institutional Investor

This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated May 15, 2020 to its short form base shelf prospectus dated April 3, 2020.OAKVILLE, Ontario, July 08, 2020 (GLOBE NEWSWIRE) — Algonquin Power & Utilities Corp. (TSX: AQN, NYSE: AQN) (“APUC”, “Algonquin” or the “Company”) today announced that it has entered into an agreement with Scotiabank and CIBC Capital Markets, on behalf of a syndicate of underwriters (the “Underwriters”), under which the Underwriters have agreed to buy, on a bought deal basis, 32,170,000 common shares of APUC (the “Common Shares”) at a price of C$17.10 per Common Share for gross proceeds of C$550 million (the “Bought Deal”). APUC has granted the Underwriters an over-allotment option, exercisable at the...

Continue reading

2020 Second Quarter Results

CONFERENCE CALL AND WEBCAST FOR INVESTORS AND ANALYSTSDate:   July 30, 2020Time:   1:00 p.m. (Eastern Time)EDMUNDSTON, New Brunswick, July 08, 2020 (GLOBE NEWSWIRE) — You are invited to participate in Acadian Timber Corp.’s 2020 second quarter conference call and webcast on Thursday, July 30, 2020 at 1:00 p.m. (Eastern Time) to discuss with members of senior management our financial and operating results.These results will be released after market close on July 29, 2020 and will be available on our website at www.acadiantimber.com under “Press Releases”.To participate in the second quarter conference call, please dial +1-866-795-3013 toll free in North America (Canada and the USA) or, for overseas calls, +1-409-937-8907 (Conference ID 8737059) at approximately 12:50 p.m. (Eastern Time). For those unable to participate, a taped...

Continue reading

DAVIDsTEA Obtains Initial Order Under Companies’ Creditors Arrangement Act

MONTREAL, July 08, 2020 (GLOBE NEWSWIRE) — DAVIDsTEA Inc. (Nasdaq:DTEA) (“DAVIDsTEA” or the “Company”), a leading tea merchant in North America, announces that it has obtained an Initial Order pursuant to the Companies’ Creditors Arrangement Act (the “CCAA”) from the Québec Superior Court in order to implement its previously-announced restructuring plan. Among other things, the Initial Order provides for the appointment of PwC as Monitor in the CCAA proceedings. As previously announced, the Company will apply for a similar order for its wholly-owned U.S. subsidiary under Chapter 15 of the United States Bankruptcy Code.A copy of the Initial Order and related documents will be available at www.pwc.com/ca/davidstea. The Company will provide updates throughout the restructuring process as events warrant.Cautionary Forward-Looking StatementsThis...

Continue reading

Les Thés DAVIDsTEA obtient une ordonnance initiale dans le cadre de la Loi sur les arrangements avec les créanciers des compagnies

MONTRÉAL, 08 juill. 2020 (GLOBE NEWSWIRE) — Les Thés DAVIDsTEA Inc. (Nasdaq: DTEA) (« DAVIDsTEA » ou la « Société »), l’un des premiers marchands de thé en Amérique du Nord, annonce qu’elle a obtenu de la Cour supérieure du Québec une ordonnance initiale dans le cadre de la Loi sur les arrangements avec les créanciers des compagnies (la « LACC ») afin de mettre en œuvre son plan de restructuration annoncé précédemment. L’ordonnance initiale prévoit notamment la nomination de PwC comme contrôleur dans le cadre de la procédure de la LACC. Comme annoncé précédemment, la Société demandera une ordonnance semblable pour sa filiale américaine en propriété exclusive en vertu du chapitre 15 du code des faillites des États-Unis.Une copie de l’ordonnance initiale et des documents connexes sera disponible sur le site www.pwc.com/ca/davidstea....

Continue reading

The New England Journal of Medicine Publishes Final Results from Phase 1/2 Study of Tofersen for a Genetic Form of ALS

Tofersen is an investigational molecule for superoxide dismutase 1 (SOD1) amyotrophic lateral sclerosis (ALS), the second most common genetic form of ALS, a progressive neurodegenerative diseaseFinal Phase 1/2 study results demonstrated proof-of-concept and proof-of-biology of tofersen, which is currently being investigated in the ongoing Phase 3 VALOR studyBiogen is committed to developing therapies that target the genetic cause of ALS and other difficult-to-treat conditionsCAMBRIDGE, Mass., July 08, 2020 (GLOBE NEWSWIRE) — Biogen Inc. (Nasdaq: BIIB) today announced that positive results from a Phase 1/2 study of tofersen (BIIB067) for the potential treatment of superoxide dismutase 1 (SOD1) amyotrophic lateral sclerosis (ALS) were published in The New England Journal of Medicine. A mutation in the SOD1 gene is believed to be a...

Continue reading

Knight Therapeutics Announces CVM Approval of the Tender Offer for remaining 48.8% of Grupo Biotoscana

MONTREAL, July 08, 2020 (GLOBE NEWSWIRE) — Knight Therapeutics Inc. (TSX: GUD) and its wholly owned subsidiary 1178991 CANADA INC. (“Knight” or “Offeror”) today announced that the Brazilian Securities and Exchange Commission (Comissão de Valores Mobiliários) (“CVM”) has approved the Tender Offer process filed by 1178991 CANADA INC. for the acquisition of all outstanding Brazilian Depositary Receipts (“BDRs”) of Biotoscana Investments S.A. (“GBT” or “Company”).The Tender Offer aims at (i) fulfilling Knight’s statutory obligation to conduct a public offer for the acquisition of the outstanding BDRs following the transfer of control (“Tag Along Tender Offer”); and (ii) the voluntary discontinuity of the BDRs program of the Company (“Discontinuity of the BDR Program”). The Tag Along Tender Offer, together with the Discontinuity...

Continue reading

Thérapeutique Knight annonce l’approbation de la CVM pour l’offre publique d’achat pour les 48,8 % restants de Grupo Biotoscana

MONTRÉAL, 08 juill. 2020 (GLOBE NEWSWIRE) — Thérapeutique Knight inc. (TSX : GUD) et sa filiale en propriété exclusive 1178991 CANADA INC. (« Knight » ou « l’offrant ») ont annoncé aujourd’hui que la Comissão de Valores Mobiliários du Brésil (« CVM »), la Securities and Exchange Commission of Brazil, a approuvé l’offre publique d’achat déposée par 1178991 CANADA INC. pour l’acquisition de tous les certificats de dépôt brésiliens (« CDB ») de Biotoscana Investments S.A. (« GBT » ou « la Société ») en circulation.L’offre publique d’achat vise (i) à remplir l’obligation statutaire de Knight de mener une offre publique d’achat pour l’acquisition des CDB en circulation suite au transfert de contrôle (« offre publique d’achat conditionnelle »); et (ii) la cessation volontaire du programme de CDB de la Société (« cessation du programme...

Continue reading

Quinto Resources reconfirms delay in filing its financial statements and MD&A for the year ended January 31, 2020 and the first quarter of 2020 due to COVID-19 related-delays

MONTREAL, July 08, 2020 (GLOBE NEWSWIRE) — Quinto Resources Inc. (TSXV: QIT) (“Quinto” or the “Company”), further to its May 29, 2020 news release, is continuing to rely on temporary relief granted by Canadian securities regulators, allowing reporting issuers to extend certain continuous disclosure filing deadlines by 45 days and reconfirms the delay in the filing of its financial statements and management’s discussion and analysis (“MD&A”) for the year ended January 31, 2020, and for the first quarter ended April 30, 2020, due to logistics and delays caused by the COVID-19 pandemic.The Company still expects to file its audited annual financial statements and accompanying MD&A on or before July 15, 2020, and now expects to file its first quarter financial statements and accompanying MD&A on or before July 31,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.